A possible new treatment option for transthyretin amyloidosis has shown promising results in an initial clinical trial. Transthyretin amyloidosis (ATTR amyloidosis) is a rare, progressive, and fatal disease...

ZURICH (Reuters) – Germany’s CureVac filed in Switzerland for a rolling review of its COVID-19 vaccine candidate, the Swiss drugs regulator Swissmedic said on Monday, as yet another maker of...

Marine algae are relatively common raw sources for cosmeceutical products.1 The photoprotective compounds identified among marine algae range from mycosporinelike amino acids, sulfated polysaccharides,...

(Reuters Health) – Studies and clinical trials funded by the Best Pharmaceuticals for Children Act (BPCA) generally enroll youth from a variety of racial and ethnic groups at proportions at or above...

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Immy Bernot watched with interest as the nurse carefully transferred a small amount of...

Higher levels of physical activity at midlife are not linked to more positive cognitive outcomes, new research suggests. Results from a cohort study of more than 1700 women showed no significant association...

Ruxolitinib cream, an investigational selective Janus kinase 1 and 2 inhibitor now under priority review by the Food and Drug Administration for the treatment of atopic dermatitis (AD) down to age 12 years,...

A new tool accurately assesses three types of anhedonia in adolescents, new research shows. The novel Multidimensional Adolescent Anhedonia Scale (MAAS) assesses anticipatory, consummatory, and recall...

ZURICH (Reuters) – Novartis’s uphill struggle to re-purpose its inflammation drug Ilaris took another hit when the Swiss drugmaker said on Tuesday that the medicine failed to boost overall...

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Canada’s challenges in procuring COVID-19 vaccines have led its researchers to look...